Pharmacokinetics, dose-response, and safety at these regimens havent been characterized in major peer-reviewed clinical trials
Interpretation of Cochrane RoB 2 Tool Using the Cochrane RoB 2 tool, all seven RCTs were judged at low risk of bias for deviations from intended interventions, missing outcome data, and measurement of outcomes, reflecting predominantly double- or triple-blind designs, minimal attrition, and the use of validated pain scales and laboratory biomarkers (Table 5 and Table 6)
And I have here my treatment proposal, it doesn't have a doctor's signature on it
You must use a sterile liquid, preferably bacteriostatic water
These reactions represent either deep tissue abscess formation or delayed Type IV hypersensitivity, both of which contraindicate continued glutathione use without provider reassessment